Report copyright - Q4/FY 2019 results Q4... · 1. Avatrombopag –approved as Doptelet for thrombocytopenia in chronic liver disease (CLD) and chronic immune thrombocytopenia (ITP) in the US. 2. Developed
Please pass captcha verification before submit form